"use client";
import React from 'react';
import Image from 'next/image';
import { Icon } from './common.jsx';

const START_URL = "https://go.telehealthfx.com/start";

function BlogZepboundVsMounjaroCompounded() {
  return (
    <>
      <section className="section" style={{ minHeight: '60vh', paddingTop: 120 }}>
      <div className="container" style={{ maxWidth: 800 }}>

        <div className="eyebrow" style={{ marginBottom: 20 }}>Medication Comparisons</div>
        <h1 className="serif" style={{ fontSize: 56, marginBottom: 24, lineHeight: 1.1 }}>
          Zepbound vs. Mounjaro vs. Compounded Tirzepatide: <span style={{ fontStyle: 'italic', color: 'var(--brand)' }}>Brand vs. Generic in 2026</span>
        </h1>
        <div style={{ display: 'flex', alignItems: 'center', gap: 12, marginBottom: 48, paddingBottom: 24, borderBottom: '1px solid var(--line-soft)' }}>
          <div style={{ width: 40, height: 40, borderRadius: '50%', background: 'var(--brand)', color: '#fff', display: 'flex', alignItems: 'center', justifyContent: 'center', fontWeight: 'bold' }}>
            <Image src="/assets/jm-profile.jpg" alt="Julian Mercer" width={1024} height={1024} style={{ width: '100%', height: '100%', objectFit: 'cover', borderRadius: '50%', height: "auto"}} priority={true} />
          </div>
          <div>
            <div style={{ fontWeight: 500, fontSize: 14 }}><a href="/about" style={{ color: "var(--ink)", textDecoration: "none" }}>Julian Mercer, M.S.</a></div>
            <div style={{ fontSize: 13, color: 'var(--ink-3)' }}>Lead Bio-Systems Analyst · Updated May 2026 · 36 min read</div>
          </div>
        </div>

        <div className="blog-content" style={{ fontSize: 18, lineHeight: 1.7, color: 'var(--ink-2)' }}>
          <Image src="/assets/zepbound-vs-mounjaro-featured.png" alt="Zepbound vs Mounjaro vs Compounded Tirzepatide comparison" width={1024} height={1024} style={{ width: '100%', borderRadius: 16, marginBottom: 40, border: '1px solid var(--line-soft)', background: '#111', height: "auto"}} priority={true} />

          <p>Tirzepatide has quickly become the most powerful <a href="/blog/what-is-a-glp-1-medication" style={{ color: 'var(--brand)', fontWeight: 500 }}>GLP-1 medication</a> on the market—and it is now available under three distinct pathways: <strong>Mounjaro</strong> (FDA-approved for type 2 diabetes), <strong>Zepbound</strong> (FDA-approved for chronic weight management), and <strong>compounded tirzepatide</strong> (prepared by licensed 503A pharmacies). All three contain the identical active molecule, yet the differences in pricing, access, insurance coverage, and regulatory status are enormous.</p>

          <p>If you have been researching tirzepatide and found yourself confused by the brand fragmentation, you are not alone. In this guide, we will break down the clinical, financial, and regulatory differences between all three options so you can make an informed decision about which pathway is right for your metabolic health goals.</p>

          <h2 className="serif" style={{ fontSize: 32, marginTop: 48, marginBottom: 24, color: 'var(--ink)' }}>Same Molecule, Three Pathways</h2>

          <p>Tirzepatide is a dual GIP/GLP-1 receptor agonist developed by Eli Lilly. Unlike semaglutide, which only activates GLP-1 receptors, tirzepatide simultaneously activates both GIP and GLP-1 receptors—producing what researchers call a "twincretin" effect. This dual mechanism delivers superior appetite suppression, enhanced insulin sensitivity, and greater total body weight loss. We explore the science behind this in our <a href="/blog/tirzepatide-vs-semaglutide-dual-agonist-mechanism" style={{ color: 'var(--brand)', fontWeight: 500 }}>dual-agonist mechanism deep dive</a>.</p>

          <div style={{ overflowX: 'auto', margin: '40px 0' }}>
            <table style={{ width: '100%', borderCollapse: 'collapse', fontSize: 16 }}>
              <thead>
                <tr style={{ borderBottom: '2px solid var(--ink)' }}>
                  <th style={{ textAlign: 'left', padding: '12px 16px', fontWeight: 600 }}>Feature</th>
                  <th style={{ textAlign: 'left', padding: '12px 16px', fontWeight: 600 }}>Mounjaro</th>
                  <th style={{ textAlign: 'left', padding: '12px 16px', fontWeight: 600 }}>Zepbound</th>
                  <th style={{ textAlign: 'left', padding: '12px 16px', fontWeight: 600 }}>Compounded</th>
                </tr>
              </thead>
              <tbody>
                <tr style={{ borderBottom: '1px solid var(--line-soft)' }}><td style={{ padding: '12px 16px' }}>FDA Indication</td><td style={{ padding: '12px 16px' }}>Type 2 Diabetes</td><td style={{ padding: '12px 16px' }}>Chronic Weight Mgmt</td><td style={{ padding: '12px 16px' }}>Patient-specific Rx</td></tr>
                <tr style={{ borderBottom: '1px solid var(--line-soft)' }}><td style={{ padding: '12px 16px' }}>List Price/mo</td><td style={{ padding: '12px 16px' }}>$1,069–$1,112</td><td style={{ padding: '12px 16px' }}>~$1,086</td><td style={{ padding: '12px 16px', color: 'var(--brand)', fontWeight: 600 }}>$200–$450</td></tr>
                <tr style={{ borderBottom: '1px solid var(--line-soft)' }}><td style={{ padding: '12px 16px' }}>Self-Pay Price</td><td style={{ padding: '12px 16px' }}>$499+</td><td style={{ padding: '12px 16px' }}>$299–$449</td><td style={{ padding: '12px 16px', color: 'var(--brand)', fontWeight: 600 }}>$200–$450</td></tr>
                <tr style={{ borderBottom: '1px solid var(--line-soft)' }}><td style={{ padding: '12px 16px' }}>Insurance Coverage</td><td style={{ padding: '12px 16px' }}>Often covered (T2D)</td><td style={{ padding: '12px 16px' }}>Limited coverage</td><td style={{ padding: '12px 16px' }}>Not covered</td></tr>
                <tr style={{ borderBottom: '1px solid var(--line-soft)' }}><td style={{ padding: '12px 16px' }}>Delivery Device</td><td style={{ padding: '12px 16px' }}>Pre-filled pen</td><td style={{ padding: '12px 16px' }}>Pre-filled pen or vial</td><td style={{ padding: '12px 16px' }}>Multi-dose vial</td></tr>
                <tr><td style={{ padding: '12px 16px' }}>FDA-Approved?</td><td style={{ padding: '12px 16px' }}>Yes</td><td style={{ padding: '12px 16px' }}>Yes</td><td style={{ padding: '12px 16px' }}>No (503A compliant)</td></tr>
              </tbody>
            </table>
          </div>

          <h2 className="serif" style={{ fontSize: 32, marginTop: 48, marginBottom: 24, color: 'var(--ink)' }}>Mounjaro: The Diabetes-First Pathway</h2>

          <p>Mounjaro was FDA-approved in May 2022 specifically for type 2 diabetes. It is <strong>not</strong> FDA-approved for weight loss, though physicians can and do prescribe it off-label for obesity. If you have a type 2 diabetes diagnosis, Mounjaro is often the most insurance-friendly option—many commercial plans cover it with a copay as low as $25/month using the manufacturer savings card.</p>

          <p>However, if you do not have a type 2 diabetes diagnosis and are seeking tirzepatide purely for weight management, obtaining Mounjaro through insurance is extremely difficult. Most plans will deny coverage for off-label use, forcing you to pay the full retail price or explore alternatives.</p>

          <h2 className="serif" style={{ fontSize: 32, marginTop: 48, marginBottom: 24, color: 'var(--ink)' }}>Zepbound: The Weight Loss Brand</h2>

          <p>Recognizing the massive weight loss market, Eli Lilly launched Zepbound in November 2023 as the dedicated weight management brand of tirzepatide. Zepbound carries the same molecule, same dosing schedule, and same efficacy as Mounjaro—the only difference is the FDA indication and the target market.</p>

          <p>Eli Lilly has been aggressive with pricing accessibility for Zepbound. The <strong>LillyDirect</strong> platform and <strong>Zepbound Self-Pay Journey</strong> program offer single-dose vials starting at approximately $299/month for the 2.5 mg starting dose, with prices increasing for higher doses. This is a significant reduction from the $1,086 list price and represents Lilly's strategic response to the compounding market.</p>

          <div className="card" style={{ padding: 40, margin: '48px 0', textAlign: 'center', background: '#FFFDF9', borderColor: 'var(--brand)' }}>
            <h3 className="serif" style={{ fontSize: 28, marginBottom: 16, color: 'var(--ink)' }}>Find Your Best Tirzepatide Option</h3>
            <p style={{ marginBottom: 24, fontSize: 16 }}>TelehealthFX clinicians help you navigate brand vs. compounded tirzepatide based on your medical history, budget, and metabolic goals.</p>
            <a href={START_URL} target="_blank" rel="noopener noreferrer" className="btn btn-primary btn-lg" style={{ display: 'inline-flex', justifyContent: 'center' }}>
              Start Your Evaluation <Icon.Arrow />
            </a>
          </div>

          <h2 className="serif" style={{ fontSize: 32, marginTop: 48, marginBottom: 24, color: 'var(--ink)' }}>Compounded Tirzepatide: Maximum Affordability</h2>

          <p>Compounded tirzepatide is prepared by licensed 503A pharmacies based on an individual, patient-specific prescription. It is <strong>not FDA-approved</strong> and has not undergone the same manufacturing review as Mounjaro or Zepbound. However, when sourced from a reputable, USP &lt;797&gt;-compliant pharmacy through a legitimate telehealth provider, it offers the most affordable pathway to tirzepatide therapy.</p>

          <p>Following the <a href="/blog/fda-compounding-ban" style={{ color: 'var(--brand)', fontWeight: 500 }}>FDA's 2026 regulatory crackdown</a>, the compounding landscape has tightened significantly. The critical consumer protection steps remain the same: verify your pharmacy is a U.S.-licensed 503A facility, confirm they use pure tirzepatide base (not unapproved salt forms), and ensure your prescribing clinician conducts genuine medical evaluations. Read our full safety guide on <a href="/blog/is-compounded-semaglutide-safe-what-you-need-to-kn" style={{ color: 'var(--brand)', fontWeight: 500 }}>compounded medication safety</a>.</p>

          <h2 className="serif" style={{ fontSize: 32, marginTop: 48, marginBottom: 24, color: 'var(--ink)' }}>Which Option Is Right for You?</h2>

          <ul>
            <li style={{ marginBottom: 16 }}><strong>You have Type 2 Diabetes + commercial insurance:</strong> Mounjaro is likely your best option. Check your formulary and apply for the manufacturer savings card ($25/month copay).</li>
            <li style={{ marginBottom: 16 }}><strong>You want weight loss + can afford $299–$449/mo:</strong> Zepbound via LillyDirect offers FDA-approved medication with self-pay pricing that competes with compounded alternatives.</li>
            <li style={{ marginBottom: 16 }}><strong>You need maximum affordability ($200–$400/mo):</strong> Compounded tirzepatide through a compliant telehealth provider like TelehealthFX offers the lowest price point with clinical oversight.</li>
            <li style={{ marginBottom: 16 }}><strong>You are comparing to semaglutide:</strong> If tirzepatide's higher cost is a barrier, compounded <a href="/medications/semaglutide" style={{ color: 'var(--brand)', fontWeight: 500 }}>semaglutide</a> remains an excellent, lower-cost alternative. See our <a href="/blog/tirzepatide-vs-semaglutide-which-glp-1-is-right-fo" style={{ color: 'var(--brand)', fontWeight: 500 }}>Tirzepatide vs. Semaglutide guide</a>.</li>
          </ul>

          <h2 className="serif" style={{ fontSize: 32, marginTop: 48, marginBottom: 24, color: 'var(--ink)' }}>Complementary Therapies to Maximize Results</h2>

          <p>Regardless of which tirzepatide pathway you choose, combining your GLP-1 therapy with evidence-based complementary treatments can significantly improve outcomes. <a href="/medications/sermorelin" style={{ color: 'var(--brand)', fontWeight: 500 }}>Sermorelin peptide therapy</a> is clinically shown to preserve lean muscle mass during rapid fat loss—a critical concern we address in our <a href="/blog/glp-1-muscle-loss-the-hidden-risk-nobodys-talking" style={{ color: 'var(--brand)', fontWeight: 500 }}>GLP-1 muscle loss</a> article. And <a href="/medications/nad" style={{ color: 'var(--brand)', fontWeight: 500 }}>NAD+ therapy</a> restores cellular energy production that can decline during aggressive caloric restriction.</p>

          <div className="card" style={{ padding: 40, margin: '48px 0', textAlign: 'center', background: '#FFFDF9', borderColor: 'var(--brand)' }}>
            <div style={{ width: 48, height: 48, borderRadius: '50%', background: 'var(--brand-soft)', color: 'var(--brand)', display: 'flex', alignItems: 'center', justifyContent: 'center', margin: '0 auto 20px' }}>
              <Icon.Check size={24} />
            </div>
            <h3 className="serif" style={{ fontSize: 28, marginBottom: 16, color: 'var(--ink)' }}>Complete Metabolic Support</h3>
            <p style={{ marginBottom: 24, fontSize: 16 }}>TelehealthFX offers tirzepatide alongside NAD+, Sermorelin, and comprehensive clinical oversight. One provider, one transparent price, zero hidden fees.</p>
            <a href={START_URL} target="_blank" rel="noopener noreferrer" className="btn btn-primary btn-lg" style={{ display: 'inline-flex', justifyContent: 'center' }}>
              Check Your Eligibility <Icon.Arrow />
            </a>
          </div>

          <h2 className="serif" style={{ fontSize: 32, marginTop: 48, marginBottom: 24, color: 'var(--ink)' }}>Frequently Asked Questions</h2>

          <h4 style={{ fontSize: 20, marginTop: 24, marginBottom: 8, color: 'var(--ink)' }}>Are Mounjaro and Zepbound the same drug?</h4>
          <p style={{ marginBottom: 24 }}>Yes. Both contain the identical active ingredient (tirzepatide) manufactured by Eli Lilly. The only difference is the FDA-approved indication: Mounjaro for type 2 diabetes, Zepbound for chronic weight management. Dosing schedules and available dose strengths are the same.</p>

          <h4 style={{ fontSize: 20, marginTop: 24, marginBottom: 8, color: 'var(--ink)' }}>Can my doctor prescribe Mounjaro for weight loss?</h4>
          <p style={{ marginBottom: 24 }}>Yes, physicians can prescribe Mounjaro off-label for weight loss. However, insurance will almost certainly deny coverage for this off-label use. You would need to pay the full retail or self-pay price, which makes Zepbound or compounded tirzepatide more cost-effective for weight-loss-only patients.</p>

          <h4 style={{ fontSize: 20, marginTop: 24, marginBottom: 8, color: 'var(--ink)' }}>Is compounded tirzepatide as effective as Zepbound?</h4>
          <p style={{ marginBottom: 24 }}>When sourced from a licensed, USP-compliant 503A pharmacy using pure tirzepatide base, the active molecule is identical. However, compounded versions have not undergone the same FDA manufacturing review and carry different regulatory protections. Efficacy depends on the quality and purity of the compounding pharmacy.</p>

          <div style={{ padding: 40, marginTop: 60, borderRadius: 20, background: 'var(--ink)', color: '#FBF8F3', textAlign: 'center' }}>
            <h2 className="serif" style={{ fontSize: 40, marginBottom: 20, color: '#FBF8F3' }}>Access Tirzepatide Today</h2>
            <p style={{ fontSize: 18, opacity: 0.9, marginBottom: 32, maxWidth: 500, margin: '0 auto 32px' }}>
              Whether you choose branded or compounded, TelehealthFX provides the clinical guidance to find your optimal pathway.
            </p>
            <a href={START_URL} target="_blank" rel="noopener noreferrer" className="btn btn-lg" style={{ background: '#FBF8F3', color: 'var(--ink)', display: 'inline-flex', justifyContent: 'center', width: '100%', maxWidth: 250 }}>
              Get Started <Icon.Arrow />
            </a>
          </div>

          <div style={{ marginTop: 80, paddingTop: 40, borderTop: '1px solid var(--line-soft)', fontSize: 14, color: 'var(--ink-3)' }}>
            <h3 className="serif" style={{ fontSize: 24, marginBottom: 24, color: 'var(--ink)' }}>Academic References &amp; Clinical Citations</h3>
            <ol style={{ paddingLeft: 20, display: 'flex', flexDirection: 'column', gap: 16 }}>
              <li>Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. <em>New England Journal of Medicine</em>, 387(3), 205–216. <a href="https://doi.org/10.1056/NEJMoa2206038" target="_blank" rel="noopener noreferrer" style={{ color: 'var(--brand)', textDecoration: 'underline' }}>https://doi.org/10.1056/NEJMoa2206038</a></li>
              <li>Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. <em>New England Journal of Medicine</em>, 385(6), 503–515. <a href="https://doi.org/10.1056/NEJMoa2107519" target="_blank" rel="noopener noreferrer" style={{ color: 'var(--brand)', textDecoration: 'underline' }}>https://doi.org/10.1056/NEJMoa2107519</a></li>
              <li>Eli Lilly and Company. (2025). <em>Zepbound (tirzepatide) prescribing information</em>. <a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217806s000lbl.pdf" target="_blank" rel="noopener noreferrer" style={{ color: 'var(--brand)', textDecoration: 'underline' }}>https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217806s000lbl.pdf</a></li>
              <li>Eli Lilly and Company. (2025). <em>Mounjaro (tirzepatide) prescribing information</em>. <a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215866s000lbl.pdf" target="_blank" rel="noopener noreferrer" style={{ color: 'var(--brand)', textDecoration: 'underline' }}>https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215866s000lbl.pdf</a></li>
              <li>U.S. Food and Drug Administration. (2026). <em>Drug Quality and Security Act: 503A vs 503B Compounding</em>. <a href="https://www.fda.gov/drugs/human-drug-compounding/drug-quality-and-security-act" target="_blank" rel="noopener noreferrer" style={{ color: 'var(--brand)', textDecoration: 'underline' }}>https://www.fda.gov/drugs/human-drug-compounding/drug-quality-and-security-act</a></li>
            </ol>
          </div>

        </div>
      </div>
    </section>
    </>
  );
}

export { BlogZepboundVsMounjaroCompounded };
